Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database

被引:0
|
作者
Megan C. Roberts
Dave P. Miller
Steven Shak
Valentina I. Petkov
机构
[1] National Cancer Institute,
[2] Genomic Health Inc.,undefined
来源
Breast Cancer Research and Treatment | 2017年 / 163卷
关键词
Breast cancer; Disease-specific survival; Lymph node-positive; Oncotype DX; Recurrence Score; SEER;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:303 / 310
页数:7
相关论文
共 50 条
  • [31] Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
    Boughey, Judy C.
    Ballman, Karla V.
    McCall, Linda M.
    Mittendorf, Elizabeth A.
    Symmans, William Fraser
    Julian, Thomas B.
    Byrd, David
    Hunt, Kelly K.
    ANNALS OF SURGERY, 2017, 266 (04) : 667 - 676
  • [32] Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer
    Dodson, Andrew
    Okonji, David
    Assersohn, Laura
    Rigg, Anne
    Sheri, Amna
    Turner, Nick
    Smith, Ian
    Parton, Marina
    Dowsett, Mitch
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 249 - 258
  • [33] MRI Radiomics and Machine Learning for the Prediction of Oncotype Dx Recurrence Score in Invasive Breast Cancer
    Romeo, Valeria
    Cuocolo, Renato
    Sanduzzi, Luca
    Carpentiero, Vincenzo
    Caruso, Martina
    Lama, Beatrice
    Garifalos, Dimitri
    Stanzione, Arnaldo
    Maurea, Simone
    Brunetti, Arturo
    CANCERS, 2023, 15 (06)
  • [34] Uptake of the 21-Gene Assay Among Women With Node-Positive, Hormone Receptor-Positive Breast Cancer
    Roberts, Megan C.
    Kurian, Allison W.
    Petkov, Valentina I.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (06): : 662 - 668
  • [35] Impact of Number of Positive Lymph Nodes and Lymph Node Ratio on Survival of Women with Node-Positive Breast Cancer
    Tonellotto, Fabiana
    Bergmann, Alike
    Abrahao, Karen de Souza
    de Aguiar, Suzana Sales
    Bello, Marcelo Adeodato
    Santos Thuler, Luiz Claudio
    EUROPEAN JOURNAL OF BREAST HEALTH, 2019, 15 (02) : 76 - 84
  • [36] The value of progesterone receptor expression in predicting the Recurrence Score for hormone-receptor positive invasive breast cancer patients
    Onoda, Toshinao
    Yamauchi, Hideko
    Yagata, Hiroshi
    Tsugawa, Koichiro
    Hayashi, Naoki
    Yoshida, Atsushi
    Suzuki, Koyu
    Sakurai, Osamu
    Nakamura, Seigo
    BREAST CANCER, 2015, 22 (04) : 406 - 412
  • [37] The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients
    Salomon M. Stemmer
    Shmuel H. Klang
    Noa Ben-Baruch
    David B. Geffen
    Mariana Steiner
    Lior Soussan-Gutman
    Shahar Merling
    Christer Svedman
    Shulamith Rizel
    Nicky Lieberman
    Breast Cancer Research and Treatment, 2013, 140 : 83 - 92
  • [38] Association of mammography and ultrasound features with MammaPrint in patients with estrogen receptor-positive, HER2-negative, node-positive invasive breast cancer
    Choi, Woo Jung
    Sim, Hayan
    Kim, Hee Jeong
    Cha, Joo Hee
    Shin, Hee Jung
    Chae, Eun Young
    Kim, Hak Hee
    ACTA RADIOLOGICA, 2021, 62 (12) : 1592 - 1600
  • [39] The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary tale from an NCDB analysis
    Weiser, Roi
    Haque, Waqar
    Polychronopoulou, Efstathia
    Hatch, Sandra S.
    Kuo, Yong-fang
    Gradishar, William J.
    Klimberg, V. Suzanne
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (03) : 667 - 676
  • [40] The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary tale from an NCDB analysis
    Roi Weiser
    Waqar Haque
    Efstathia Polychronopoulou
    Sandra S. Hatch
    Yong-fang Kuo
    William J. Gradishar
    V. Suzanne Klimberg
    Breast Cancer Research and Treatment, 2021, 185 : 667 - 676